Interferon-α as first-line therapy for treatment of multicentric Castleman's disease

Annals of Oncology

Volumn 11, Issue 12, 2000, Pages 1613-1614

  Andres E ^a   Maloisel, F ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Castleman's disease; Interferon

Indexed keywords

ALPHA INTERFERON; CYTOKINE; IMMUNOGLOBULIN;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL;

BIOLOGICAL RESPONSE MODIFIERS; DOWN-REGULATION; GIANT LYMPH NODE HYPERPLASIA; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6;

EID: 0034489946     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008325114144     Document Type: Article

References (6)

1. The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of literature
2. Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support
3. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
4. Retinoic acid for treatment of multicentric Castleman's disease
5. Interferon-α an active agent in Castleman's disease?
6. Long-term complete remission after interferon treatment in a case of multicentric Castleman's disease